Repression of oxidant-induced nuclear factor-κB activity mediates placental cytokine responses in gestational diabetes

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 7, 2004, Pages 3585-3594

  Coughlan, Melinda T ^a,b   Permezel, Michael ^a   Georgiou, Harry M ^a   Rice, Gregory E ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DNA BINDING; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN SENSITIVITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL;

ADULT; ANTIOXIDANTS; CASE-CONTROL STUDIES; CYTOKINES; DIABETES, GESTATIONAL; DNA; FEMALE; HUMANS; HYPOXANTHINE; ISOPROSTANES; LIPOPOLYSACCHARIDES; NF-KAPPA B; OXIDATIVE STRESS; PLACENTA; PREGNANCY; PROTEIN ISOFORMS; THIOCTIC ACID; TUMOR NECROSIS FACTOR-ALPHA;

EID: 3242657864     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-031953     Document Type: Article

References (43)

1. Metzger BE, Coustan DR 1998 Proceedings of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 21(Suppl 2):B1-B167
2. Dornhorst A, Bailey PC, Anyaoku V, Elkeles RS, Johnston DG, Beard RW 1990 Abnormalities in glucose tolerance following gestational diabetes. Q J Med 77:1219-1228
3. Pendergrass M, Fazioni E, De Fronzo R 1995 Non-insulin-dependent diabetes mellitus and gestational diabetes mellitus: same disease, another name? Diabetes Rev 3:566-583
4. Baynes JW 1991 Role of oxidative stress in development of complications in diabetes. Diabetes 40:405-412
5. West IC 2000 Radicals and oxidative stress in diabetes. Diabet Med 17:171-180
6. Droge W 2002 Free radicals in the physiological control of cell function. Physiol Rev 82:47-95
7. Haddad JJ 2002 Oxygen homeostasis, thiol equilibrium and redox regulation of signalling transcription factors in the alveolar epithelium. Cell Signal 14:799-810
8. Barnes PJ, Karin M 1997 Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066-1071
9. Rice GE 2001 Cytokines and the initiation of parturition. Front Horm Res 27:113-146
10. Grimble RF 2002 Inflammatory status and insulin resistance. Curr Opin Clin Nutr Metab Care 5:551-559
11. Richelsen B, Bruun JM, Pedersen SB 2001 Fatty tissue as a secretory organ: significance for obesity-related diseases. Ugeskr Laeger 163:2913-2917
12. Lappas M, Permezel M, Georgiou HM, Rice GE 2002 Nuclear factor κB regulation of proinflammatory cytokines in human gestational tissues in vitro. Biol Reprod 67:668-673
13. Coughlan MT, Oliva K, Georgiou HM, Permezel HMJ, Rice GE 2001 Glucose-induced release of TNF-α from human placental and adipose tissues in gestational diabetes mellitus. Diabet Med 18:921-927
14. Hoffman L, Nolart C, Wilson JD, Oats JJN, Simmons D 1998 Gestational diabetes mellitus management guidelines. The Australasian Diabetes in Pregnancy Society. Med J Aust 169:93-97
15. 2 from human placenta. J Endocrinol 160:291-296
16. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical catalyzed mechanism. Proc Natl Acad Sci USA 87:9383-9387
17. Lu D, Maulik N, Moraru II, Kreutzer DL, Das DK 1993 Molecular adaptation of vascular endothelial cells to oxidative stress. Am J Physiol 264:C715-C722
18. Bonnefont-Rousselot D 2002 Glucose and reactive oxygen species. Curr Opin Clin Nutr Metab Care 5:561-568
19. Kinalski M, Sledziewski A, Telejko B, Kowalska I, Kretowski A, Zarzycki W, Kinalska I 2001 Lipid peroxidation, antioxidant defence and acid-base status in cord blood at birth: the influence of diabetes. Horm Metab Res 33:227-231
20. Coughlan MT, Vervaart PP, Permezel M, Georgiou HM, Rice GE 2004 Altered placental oxidative stress status in gestational diabetes mellitus. Placenta 25:78-84
21. 2-isoprostanes) in smokers: smoking as a cause of oxidative damage. N Engl J Med 332:1198-1203
22. 2 isoprostanes: direct evidence of increased free radical damage during acute hyperglycemia in type 2 diabetes. Diabetes Care 25:537-541
23. Katsuki A, Sumida Y, Murashima S, Murata K, Takarada Y, Ho K, Fujii M, Tsuchihashi K, Goto H, Nakatani K, Yano Y 1998 Serum levels of rumor necrosis factor-α are increased in obese patients with NIDDM. J Clin Endocrinol Metab 83:859-862
24. Winkler G, Cseh K, Baranyi E, Melczer Z, Speer G, Hajos P, Salamon F, Turi Z, Kovacs M, Vargha P, Karadi I 2002 Tumor necrosis factor system in insulin resistance in gestational diabetes. Diabetes Res Clin Pract 56:93-99
25. Kirwan JP, Hauguel-De Mouzon S, Lepercq J, Challier JC, Huston-Presley L, Friedman JE, Kalhan SC, Catalano PM 2002 TNF-α is a predictor of insulin resistance in human pregnancy. Diabetes 51:2207-2213
26. Kanety H, Feinstein R, Papa MZ, Hemi R, Karasik A 1995 Tumour necrosis factor α-induced phosphorylation of insulin receptor substrate-1 (IRS-1). Possible mechanism for suppression of insulin-stimulated tyrosine phosphorylation of IRS-1. J Biol Chem 270:23780-23784
27. Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM 1994 Tumour necrosis factor α inhibits signaling from the insulin receptor. Proc Natl Acad Sci USA 91:4854-4858
28. Malek A, Sager R, Schneider H 2001 Effect of hypoxia, oxidative stress and lipopolysaccharides on the release of prostaglandins and cytokines from human term placental explants. Placenta 15:S45-S50
29. Kosmidou I, Vassilakopoulos T, Xagorari A, Zakynthinos S, Papapetropoulos A, Roussos C 2002 Production of IL-6 by skeletal myotubes: role of reactive oxygen species. Am J Respir Cell Mol Biol 26:587-593
30. Scott NA, Jennings PE, Brown J, Belch JJ 1991 Gliclazide: a general free radical scavenger. Eur J Pharmacol 208:175-177
31. Inoue I, Katayama S, Takahashi K, Negishi K, Miyazaki T, Sonoda M, Komoda T 1997 Troglitazone has a scavenging effect on reactive oxygen species. Biochem Biophys Res Commun 235:113-116
32. Evans JL, Goldfine ID 2000 α-Lipoic acid: a multifunctional antioxidant that improves insulin sensitivity in patients with type 2 diabetes. Diabetes Technol Ther 2:401-413
33. Katsuki A, Sumida Y, Murata K, Furuta M, Araki-Sasaki R, Tsuchihashi K, Hori Y, Yano Y, Gabazza EC, Adachi Y 2000 Troglitazone reduces plasma levels of tumour necrosis factor-a in obese patients with type 2 diabetes. Diabetes Obes Metab 2:189-191
34. Desfaits AC, Serri O, Renier G 1998 Normalization of plasma lipid peroxides, monocyte adhesion, and tumor necrosis factor-α production in NIDDM patients after gliclazide treatment. Diabetes Care 21:487-493
35. 2 and troglitazone. J Clin Endocrinol Metab 87:4667-4672
36. Berger J, Moller DE 2002 The mechanisms of action of PPARs. Annu Rev Med 53:409-435
37. Chawla A, Schwarz EJ, Dimaculangan DD, Lazar MA 1994 Peroxisome proliferator-activated receptor (PPAR) γ: adipose-predominant expression and induction early in adipocyte differentiation. Endocrinology 135:798-800
38. Wang Q, Fujii H, Knipp GT 2002 Expression of PPAR and RXR isoforms in the developing rat and human term placentas. Placenta 23:661-671
39. Thibodeau PA, Kachadourian R, Lemay R, Bisson M, Day BJ, Paquette B 2002 In vitro pro- and antioxidant properties of estrogens. J Steroid Biochem Mol Biol 81:227-236
40. Zhu XD, Bonet B, Knopp RH 1997 17β-Estradiol, progesterone, and testosterone inversely modulate low-density lipoprotein oxidation and cytotoxicity in cultured placental trophoblast and macrophages. Am J Obstet Gynecol 177:196-209
41. Pierce JW, Schoenleber R, Jesmok G, Best J, Moore SA, Collins T, Gerritsen ME 1997 Novel inhibitors of cytokine-induced IκBα phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J Biol Chem 272:21096-21103
42. 2 and cyclooxygenases in human placenta, fetal membranes, and chorionic cell lines. Prostaglandins Other Lipid Mediat 60:119-125
43. Lappas M, Permezel M, Rice GE 2003 N-acetyl-cysteine inhibits phospholipid metabolism, pro-inflammatory cytokine release, protease activity, and nuclear factor-κB deoxyribonucleic acid-binding activity in human fetal membranes in vitro. J Clin Endocrinol Metab 88:1723-1729